A Multicentre Study: The Use of Micrografts in the Reconstruction of Full-Thickness Posttraumatic Skin Defects of the Limbs—A Whole Innovative Concept in Regenerative Surgery

Table 1

Patients and wound description.

	(%)	Mean value	Minimum-maximum
Patients
Total	70 (100%)
Sex
Male	32 (23%)
Female	38 (27%)
Age		53 years	34-74 years
Underlying disease
None	49 (70%)
Diabetes type II	15 (22%)
Arteriopathy	6 (8%)
Wound description
Wound location
Thigh	6 (8%)
Leg	30 (43%)
Ankle	19 (28%)
Foot	15 (21%)
Type of injury
Wound dehiscence	18 (26%)
Posttraumatic ulcer	32 (45%)
Metabolic ulcer	18 (26%)
Burn	2 (3%)
Surface area		14 cm^2	7-28 cm^2
Exposed structures
None	34 (49%)
Tendon	12 (17%)
Bone	24 (34%)
Rigenera procedure
Infection
Before procedure	8 (11%)
After procedure	0 (0%)
Rigenera treatment delay after trauma		7 weeks	2-18 weeks
Antibiotics postoperative	70 (100%)	6 days	6 days
Time of complete healing		48 days	35-84 days
None (S-J syndrome)	1 (1%)
Complication/note
None	66 (95%)
Stevens-Johnson syndrome	1 (1%)
Associate use (Rigenera+Integra®)	3 (4%)